Check out the online TTS 2024 Program

Time	Room	Session
07:00 - 08:00 \| Morning Sessions
07:00-08:00	MOA 6	MOA 6 07:00 Morning Session: WIT Session Full Details Session Sponsored by: Sandy Feng, United States Let’s Chat: Professional Opportunities and Choices Sandy Feng, United States Let’s Chat: Professional Opportunities and Choices
07:00-07:50	MOA 4	MOA 4 07:00 Oral Abstract: Kidney transplantation Full Details Burkhard Toenshoff, Germany Risk assessment of delayed graft function in pediatric kidney transplantation – A CERTAIN research network analysis Burkhard Toenshoff, Germany Risk assessment of delayed graft function in pediatric kidney transplantation – A CERTAIN research network analysis Ni Nyoman Berlian Aryadevi, Indonesia Safety profile of antiviral prophylaxis for cytomegalovirus in pediatric kidney transplant patients: a systematic review Ni Nyoman Berlian Aryadevi, Indonesia Safety profile of antiviral prophylaxis for cytomegalovirus in pediatric kidney transplant patients: a systematic review Marco Cugliari, Italy BK polyomavirus infection in pediatric renal transplant recipients - a 10 year single center experience Marco Cugliari, Italy BK polyomavirus infection in pediatric renal transplant recipients - a 10 year single center experience Gauthier Gernay, Belgium Pediatric robot-assisted kidney transplantation: Largest European series Gauthier Gernay, Belgium Pediatric robot-assisted kidney transplantation: Largest European series
07:00-07:50	MOA 3	MOA 3 07:00 Oral Abstract: Liver transplantation - expanding the donor pool Full Details Adem Safak, Turkey Maximizing donor utilization: The role of domino liver transplantation in overcoming organ shortage Adem Safak, Turkey Maximizing donor utilization: The role of domino liver transplantation in overcoming organ shortage Isabel González-Barba Neira, Spain The impact of prioritizing pediatric recipients on a national scale: Battling waitlist morbidity and encouraging the diversification of liver transplant indications Isabel González-Barba Neira, Spain The impact of prioritizing pediatric recipients on a national scale: Battling waitlist morbidity and encouraging the diversification of liver transplant indications Srinath Chinnakotla, United States ABO incompatible deceased donor liver transplants in infants (age <1 Year): a single-center experience Srinath Chinnakotla, United States ABO incompatible deceased donor liver transplants in infants (age <1 Year): a single-center experience Christine Hwang, United States Practice Patterns of Normothermic Machine Perfusion Use in Pediatric Liver Transplantation Christine Hwang, United States Practice Patterns of Normothermic Machine Perfusion Use in Pediatric Liver Transplantation Alessandra Rancan, France Daratumumab as a rescue therapy for antibody-mediated rejection in super-urgent ABO- incompatible pediatric liver transplantation Alessandra Rancan, France Daratumumab as a rescue therapy for antibody-mediated rejection in super-urgent ABO- incompatible pediatric liver transplantation
08:00 - 09:00 \| Concurrent Workshop Sessions
08:00-09:00	MOA 6	MOA 6 08:00 Workshop: Progress in infectious disease diagnosis, management, and mitigation in the immunocompromised host Full Details Sanya J Thomas, United States Burden and prevention of invasive fungal infection in pediatric solid organ transplant Sanya J Thomas, United States Burden and prevention of invasive fungal infection in pediatric solid organ transplant Arnaud G. L'huillier, Switzerland Reconsidering CNS disease in the donor, are newer diagnostics allowing further risk stratification? Arnaud G. L'huillier, Switzerland Reconsidering CNS disease in the donor, are newer diagnostics allowing further risk stratification? Upton Allen, Canada Updates on EBV and post-transplant lymphoproliferative disorders in solid organ transplant Upton Allen, Canada Updates on EBV and post-transplant lymphoproliferative disorders in solid organ transplant
08:00-09:00	MOA 5	MOA 5 08:00 Workshop: IPTA-ESOT: Innovation in transplantation Full Details Session Sponsored by: Abanti Chaudhuri, United States Sequential stem cell-renal transplant Abanti Chaudhuri, United States Sequential stem cell-renal transplant Jelena Stojanovic, United Kingdom New indications for transplantation: complex transplantation Jelena Stojanovic, United Kingdom New indications for transplantation: complex transplantation
08:00-09:00	MOA 4	MOA 4 08:00 Workshop: To Transplant or not to Transplant, that is the Question: Considering the Ethics of Re- transplantation after nonadherence Full Details Tom Blydt-Hansen, Canada Session introduction and information about polling system Tom Blydt-Hansen, Canada Session introduction and information about polling system Debra Lefkowitz, United States Psychosocial factors impacting nonadherence and preventive strategies Debra Lefkowitz, United States Psychosocial factors impacting nonadherence and preventive strategies Ali Asghar A Lanewala, Pakistan Ethical considerations of retransplantation in child with prior nonadherence Ali Asghar A Lanewala, Pakistan Ethical considerations of retransplantation in child with prior nonadherence Katheryn Gambetta, United States The clinician’s perspective: Moderated interactive discussion with audience participation Katheryn Gambetta, United States The clinician’s perspective: Moderated interactive discussion with audience participation
08:00-09:00	MOA 3	MOA 3 08:00 Workshop: Multiorgan considerations in metabolic disorders Full Details Michael O Stormon, Australia Metabolic diseases that commonly need multiorgan transplant Michael O Stormon, Australia Metabolic diseases that commonly need multiorgan transplant Ane M. Andres, Spain Peri-transplant considerations for metabolic patients receiving multiorgan transplants Ane M. Andres, Spain Peri-transplant considerations for metabolic patients receiving multiorgan transplants Jemma Mears, United Kingdom The multidisciplinary approach to caring for metabolic patients requiring multiorgan transplant Jemma Mears, United Kingdom The multidisciplinary approach to caring for metabolic patients requiring multiorgan transplant Discussion Period, Germany Panel Discussion Discussion Period, Germany Panel Discussion
09:00 - 09:15 \| Coffee Break
09:00-09:15	Foyer Area	Foyer Area 09:00 Coffee Break Full Details
09:15 - 10:45 \| Abstract Sessions
09:15-10:45	MOA 6	MOA 6 09:15 Oral Abstract: Monitoring after pediatric kidney transplant Full Details Elodie Cheyssac, France Performance of cystatin-based formulas to estimate glomerular filtration rate in pediatric kidney transplant recipients. Elodie Cheyssac, France Performance of cystatin-based formulas to estimate glomerular filtration rate in pediatric kidney transplant recipients. Evgenia Preka, France Design and protocol of an international multicentre study on molecular profiling of allograft rejection in paediatric kidney transplant patients: the PANDA-Kids-ATLAS study. Evgenia Preka, France Design and protocol of an international multicentre study on molecular profiling of allograft rejection in paediatric kidney transplant patients: the PANDA-Kids-ATLAS study. Chen Rosenberg Danziger, Israel Rate of eGFR improvement early post-transplant and long-term graft outcome in pediatric renal transplantation Chen Rosenberg Danziger, Israel Rate of eGFR improvement early post-transplant and long-term graft outcome in pediatric renal transplantation Tim A. Ubenauf, Germany Identifying high-risk hearts after pediatric kidney transplantation: linking diastolic dysfunction to myocardial fibrosis Tim A. Ubenauf, Germany Identifying high-risk hearts after pediatric kidney transplantation: linking diastolic dysfunction to myocardial fibrosis Vaka K Sigurjonsdottir, United States Impact of HLA-DQα05 Heterodimer Mismatch on De Novo Donor-Specific Antibody Formation in Pediatric Kidney Transplantation Vaka K Sigurjonsdottir, United States Impact of HLA-DQα05 Heterodimer Mismatch on De Novo Donor-Specific Antibody Formation in Pediatric Kidney Transplantation Julien Hogan, France Thrombotic and Hemorrhagic Events After Pediatric Kidney Transplantation: A Single-Center Assessment of Anticoagulation Protocol Julien Hogan, France Thrombotic and Hemorrhagic Events After Pediatric Kidney Transplantation: A Single-Center Assessment of Anticoagulation Protocol Helen Pizzo, United States Risk factors for loss of varicella immunity after pediatric kidney transplantation Helen Pizzo, United States Risk factors for loss of varicella immunity after pediatric kidney transplantation Carl Grabitz, Germany Continuous long term exposure to lower blood pressure stabilizes kidney graft function and improves graft survival in children Carl Grabitz, Germany Continuous long term exposure to lower blood pressure stabilizes kidney graft function and improves graft survival in children
09:15-10:45	MOA 5	MOA 5 09:15 Oral Abstract: Complications of pediatric liver transplantation Full Details Maria Julia Minetto, Argentina HLA molecular mismatch as a predictor of rejection and donor-specific antibodies in pediatric liver transplantation Maria Julia Minetto, Argentina HLA molecular mismatch as a predictor of rejection and donor-specific antibodies in pediatric liver transplantation Yuan Liu, People's Republic of China Oral application of low-dosage prednisone is efficient in reversing allograft fibrosis during long-term follow-up Yuan Liu, People's Republic of China Oral application of low-dosage prednisone is efficient in reversing allograft fibrosis during long-term follow-up Ane M. Andres, Spain Flow measurement in pediatric liver transplantation: a pilot study Ane M. Andres, Spain Flow measurement in pediatric liver transplantation: a pilot study Lydia Sieben, Netherlands Safety and efficacy of PTA and stent placement for portal vein stenosis after pediatric liver transplantation; findings from the PORTAL registry Lydia Sieben, Netherlands Safety and efficacy of PTA and stent placement for portal vein stenosis after pediatric liver transplantation; findings from the PORTAL registry Amanda R Jensen, United States Age matching improves graft survival in adolescent liver transplantation Amanda R Jensen, United States Age matching improves graft survival in adolescent liver transplantation Lin Wei, People's Republic of China Liver Transplantation for Acute Liver Failure: Auxiliary or Non-Auxiliary Transplantation? Lin Wei, People's Republic of China Liver Transplantation for Acute Liver Failure: Auxiliary or Non-Auxiliary Transplantation? Benas Prusinskas, Lithuania 2D-Shear Wave Elastography of Pediatric Liver Transplants Benas Prusinskas, Lithuania 2D-Shear Wave Elastography of Pediatric Liver Transplants Min Kyoung Kim, Korea Long-term outcomes of percutaneous stent angioplasty for vein stenosis after pediatric liver transplantation Min Kyoung Kim, Korea Long-term outcomes of percutaneous stent angioplasty for vein stenosis after pediatric liver transplantation Weihao Li, Netherlands Poor one-year outcomes of hepatic artery thrombosis after pediatric liver transplantation: Results from an international, multicenter, real-world registry Weihao Li, Netherlands Poor one-year outcomes of hepatic artery thrombosis after pediatric liver transplantation: Results from an international, multicenter, real-world registry
09:15-10:45	MOA 4	MOA 4 09:15 Oral Abstract: Insights in immunology and immunosuppression Full Details Burkhard Toenshoff, Germany Association of intraindividual tacrolimus variability and concentration-to-dose ratio with allograft rejection in pediatric kidney transplant recipients Burkhard Toenshoff, Germany Association of intraindividual tacrolimus variability and concentration-to-dose ratio with allograft rejection in pediatric kidney transplant recipients Lynn Maestretti, United States Evaluating the Risk and Benefit of Once Daily Mycophenolate Acid in Pediatric Kidney Transplant Recipients Lynn Maestretti, United States Evaluating the Risk and Benefit of Once Daily Mycophenolate Acid in Pediatric Kidney Transplant Recipients David Nehl, Germany Immune Monitoring by Torque-Teno Virus Load in Addition to Virus-Specific T Cells After Pediatric Kidney Transplantation David Nehl, Germany Immune Monitoring by Torque-Teno Virus Load in Addition to Virus-Specific T Cells After Pediatric Kidney Transplantation Katherine D Westreich, United States Outcomes after basiliximab, thymoglobulin, or alemtuzumab induction for pediatric kidney transplant: A single center study Katherine D Westreich, United States Outcomes after basiliximab, thymoglobulin, or alemtuzumab induction for pediatric kidney transplant: A single center study Martin Jaros, Germany Insights into the Interplay between Senescent Cells and Immune Cells in the Kidney Microenvironment Martin Jaros, Germany Insights into the Interplay between Senescent Cells and Immune Cells in the Kidney Microenvironment Anna Quarder, Germany Sex differences in endothelial cell senescence are independent of gonadal-hormones Anna Quarder, Germany Sex differences in endothelial cell senescence are independent of gonadal-hormones Sandra Amaral, United States Evaluating Feasibility and Clinical Relevance of Pharmacogenomic Testing using Whole Genome Sequencing in Pediatric Kidney Transplantation Sandra Amaral, United States Evaluating Feasibility and Clinical Relevance of Pharmacogenomic Testing using Whole Genome Sequencing in Pediatric Kidney Transplantation Sierra Scodellaro, Canada Pharmacogenetics in pediatric kidney transplant: Leveraging CYP3A5-guided therapy for improved patient outcomes Sierra Scodellaro, Canada Pharmacogenetics in pediatric kidney transplant: Leveraging CYP3A5-guided therapy for improved patient outcomes Brian Madden, United States CD4 counts exhibit poor recovery in pediatric transplant patients with single ventricle physiology Brian Madden, United States CD4 counts exhibit poor recovery in pediatric transplant patients with single ventricle physiology
09:15-10:45	MOA 3	MOA 3 09:15 Oral Abstract: Transplant variety - Education, adherence, and multi-organ transplantation Full Details Katheryn Gambetta, United States Global Perspectives on Nonadherence and Re-Transplantation in Pediatric Solid Organ Transplant Recipients: an IPTA Ethics Committee Analysis Katheryn Gambetta, United States Global Perspectives on Nonadherence and Re-Transplantation in Pediatric Solid Organ Transplant Recipients: an IPTA Ethics Committee Analysis Stefany Hernandez Benabe, United States The Global Pediatric Transplant Centers Map (GPTCM): A collaborative advocacy initiative Stefany Hernandez Benabe, United States The Global Pediatric Transplant Centers Map (GPTCM): A collaborative advocacy initiative Luz Yadira Bravo-Gallego, Spain The European Paediatric Transplant Registry (PETER): the international registry of the European Reference Network on Transplantation in Children (ERN-TRANSPLANTCHILD) Luz Yadira Bravo-Gallego, Spain The European Paediatric Transplant Registry (PETER): the international registry of the European Reference Network on Transplantation in Children (ERN-TRANSPLANTCHILD) Clare J Lindner, United States Combined Liver-Kidney Transplant in Children Clare J Lindner, United States Combined Liver-Kidney Transplant in Children Lars Pape, Germany Medication adherence and outcomes after pediatric kidney transplantation: Results from the telemedicine-based, multimodal aftercare program KTx360° Lars Pape, Germany Medication adherence and outcomes after pediatric kidney transplantation: Results from the telemedicine-based, multimodal aftercare program KTx360° Carmen Capito, France Combined islet and liver transplantation in children Carmen Capito, France Combined islet and liver transplantation in children Ana Petrović, Serbia Follow-up of combined liver-kidney transplant pediatric recipients – single center experience Ana Petrović, Serbia Follow-up of combined liver-kidney transplant pediatric recipients – single center experience Rebecca Mercedes, United States Surveying the landscape of pediatric transplant training: does access need to be expanded? Rebecca Mercedes, United States Surveying the landscape of pediatric transplant training: does access need to be expanded?
10:50 - 12:30 \| Plenary and Closing Session
10:50-12:30	MOA 9 (Plenary Room)	MOA 9 (Plenary Room) 10:50 Plenary Session: Xenotransplant – A Role in pediatric transplantation Full Details Simon Urschel, Canada How Xeno might be feasible in children with naïve immune systems Simon Urschel, Canada How Xeno might be feasible in children with naïve immune systems Jayme E. Locke, United States Pediatric Xeno transplant: Crossing the barrier of Xeno-AMR Jayme E. Locke, United States Pediatric Xeno transplant: Crossing the barrier of Xeno-AMR Eckhard Nagel, Germany Ethics in xenotransplant Eckhard Nagel, Germany Ethics in xenotransplant

07:00-08:00

MOA 6

07:00

Morning Session: WIT Session

Full Details

Session Sponsored by:

Sandy Feng, United States
Let’s Chat: Professional Opportunities and Choices

07:00-07:50

MOA 4

07:00

Oral Abstract: Kidney transplantation

Full Details

Burkhard Toenshoff, Germany
Risk assessment of delayed graft function in pediatric kidney transplantation – A CERTAIN research network analysis

Ni Nyoman Berlian Aryadevi, Indonesia
Safety profile of antiviral prophylaxis for cytomegalovirus in pediatric kidney transplant patients: a systematic review

Marco Cugliari, Italy
BK polyomavirus infection in pediatric renal transplant recipients - a 10 year single center experience

Gauthier Gernay, Belgium
Pediatric robot-assisted kidney transplantation: Largest European series

07:00-07:50

MOA 3

07:00

Oral Abstract: Liver transplantation - expanding the donor pool

Full Details

Adem Safak, Turkey
Maximizing donor utilization: The role of domino liver transplantation in overcoming organ shortage

Isabel González-Barba Neira, Spain
The impact of prioritizing pediatric recipients on a national scale: Battling waitlist morbidity and encouraging the diversification of liver transplant indications

Srinath Chinnakotla, United States
ABO incompatible deceased donor liver transplants in infants (age <1 Year): a single-center experience

Christine Hwang, United States
Practice Patterns of Normothermic Machine Perfusion Use in Pediatric Liver Transplantation

Alessandra Rancan, France
Daratumumab as a rescue therapy for antibody-mediated rejection in super-urgent ABO- incompatible pediatric liver transplantation

08:00-09:00

MOA 6

08:00

Workshop: Progress in infectious disease diagnosis, management, and mitigation in the immunocompromised host

Full Details

Sanya J Thomas, United States
Burden and prevention of invasive fungal infection in pediatric solid organ transplant

Arnaud G. L'huillier, Switzerland
Reconsidering CNS disease in the donor, are newer diagnostics allowing further risk stratification?

Upton Allen, Canada
Updates on EBV and post-transplant lymphoproliferative disorders in solid organ transplant

08:00-09:00

MOA 5

08:00

Workshop: IPTA-ESOT: Innovation in transplantation

Full Details

Session Sponsored by:

Abanti Chaudhuri, United States
Sequential stem cell-renal transplant

Jelena Stojanovic, United Kingdom
New indications for transplantation: complex transplantation

08:00-09:00

MOA 4

08:00

Workshop: To Transplant or not to Transplant, that is the Question: Considering the Ethics of Re- transplantation after nonadherence

Full Details

Tom Blydt-Hansen, Canada
Session introduction and information about polling system

Debra Lefkowitz, United States
Psychosocial factors impacting nonadherence and preventive strategies

Ali Asghar A Lanewala, Pakistan
Ethical considerations of retransplantation in child with prior nonadherence

Katheryn Gambetta, United States
The clinician’s perspective: Moderated interactive discussion with audience participation

08:00-09:00

MOA 3

08:00

Workshop: Multiorgan considerations in metabolic disorders

Full Details

Michael O Stormon, Australia
Metabolic diseases that commonly need multiorgan transplant

Ane M. Andres, Spain
Peri-transplant considerations for metabolic patients receiving multiorgan transplants

Jemma Mears, United Kingdom
The multidisciplinary approach to caring for metabolic patients requiring multiorgan transplant

Discussion Period, Germany
Panel Discussion

09:00-09:15

Foyer Area

09:00

Coffee Break

Full Details

09:15-10:45

MOA 6

09:15

Oral Abstract: Monitoring after pediatric kidney transplant

Full Details

Elodie Cheyssac, France
Performance of cystatin-based formulas to estimate glomerular filtration rate in pediatric kidney transplant recipients.

Evgenia Preka, France
Design and protocol of an international multicentre study on molecular profiling of allograft rejection in paediatric kidney transplant patients: the PANDA-Kids-ATLAS study.

Chen Rosenberg Danziger, Israel
Rate of eGFR improvement early post-transplant and long-term graft outcome in pediatric renal transplantation

Tim A. Ubenauf, Germany
Identifying high-risk hearts after pediatric kidney transplantation: linking diastolic dysfunction to myocardial fibrosis

Vaka K Sigurjonsdottir, United States
Impact of HLA-DQα05 Heterodimer Mismatch on De Novo Donor-Specific Antibody Formation in Pediatric Kidney Transplantation

Julien Hogan, France
Thrombotic and Hemorrhagic Events After Pediatric Kidney Transplantation: A Single-Center Assessment of Anticoagulation Protocol

Helen Pizzo, United States
Risk factors for loss of varicella immunity after pediatric kidney transplantation

Carl Grabitz, Germany
Continuous long term exposure to lower blood pressure stabilizes kidney graft function and improves graft survival in children

09:15-10:45

MOA 5

09:15

Oral Abstract: Complications of pediatric liver transplantation

Full Details

Maria Julia Minetto, Argentina
HLA molecular mismatch as a predictor of rejection and donor-specific antibodies in pediatric liver transplantation

Yuan Liu, People's Republic of China
Oral application of low-dosage prednisone is efficient in reversing allograft fibrosis during long-term follow-up

Ane M. Andres, Spain
Flow measurement in pediatric liver transplantation: a pilot study

Lydia Sieben, Netherlands
Safety and efficacy of PTA and stent placement for portal vein stenosis after pediatric liver transplantation; findings from the PORTAL registry

Amanda R Jensen, United States
Age matching improves graft survival in adolescent liver transplantation

Lin Wei, People's Republic of China
Liver Transplantation for Acute Liver Failure: Auxiliary or Non-Auxiliary Transplantation?

Benas Prusinskas, Lithuania
2D-Shear Wave Elastography of Pediatric Liver Transplants

Min Kyoung Kim, Korea
Long-term outcomes of percutaneous stent angioplasty for vein stenosis after pediatric liver transplantation

Weihao Li, Netherlands
Poor one-year outcomes of hepatic artery thrombosis after pediatric liver transplantation: Results from an international, multicenter, real-world registry

09:15-10:45

MOA 4

09:15

Oral Abstract: Insights in immunology and immunosuppression

Full Details

Burkhard Toenshoff, Germany
Association of intraindividual tacrolimus variability and concentration-to-dose ratio with allograft rejection in pediatric kidney transplant recipients

Lynn Maestretti, United States
Evaluating the Risk and Benefit of Once Daily Mycophenolate Acid in Pediatric Kidney Transplant Recipients

David Nehl, Germany
Immune Monitoring by Torque-Teno Virus Load in Addition to Virus-Specific T Cells After Pediatric Kidney Transplantation

Katherine D Westreich, United States
Outcomes after basiliximab, thymoglobulin, or alemtuzumab induction for pediatric kidney transplant: A single center study

Martin Jaros, Germany
Insights into the Interplay between Senescent Cells and Immune Cells in the Kidney Microenvironment

Anna Quarder, Germany
Sex differences in endothelial cell senescence are independent of gonadal-hormones

Sandra Amaral, United States
Evaluating Feasibility and Clinical Relevance of Pharmacogenomic Testing using Whole Genome Sequencing in Pediatric Kidney Transplantation

Sierra Scodellaro, Canada
Pharmacogenetics in pediatric kidney transplant: Leveraging CYP3A5-guided therapy for improved patient outcomes

Brian Madden, United States
CD4 counts exhibit poor recovery in pediatric transplant patients with single ventricle physiology

09:15-10:45

MOA 3

09:15

Oral Abstract: Transplant variety - Education, adherence, and multi-organ transplantation

Full Details

Katheryn Gambetta, United States
Global Perspectives on Nonadherence and Re-Transplantation in Pediatric Solid Organ Transplant Recipients: an IPTA Ethics Committee Analysis

Stefany Hernandez Benabe, United States
The Global Pediatric Transplant Centers Map (GPTCM): A collaborative advocacy initiative

Luz Yadira Bravo-Gallego, Spain
The European Paediatric Transplant Registry (PETER): the international registry of the European Reference Network on Transplantation in Children (ERN-TRANSPLANTCHILD)

Clare J Lindner, United States
Combined Liver-Kidney Transplant in Children

Lars Pape, Germany
Medication adherence and outcomes after pediatric kidney transplantation: Results from the telemedicine-based, multimodal aftercare program KTx360°

Carmen Capito, France
Combined islet and liver transplantation in children

Ana Petrović, Serbia
Follow-up of combined liver-kidney transplant pediatric recipients – single center experience

Rebecca Mercedes, United States
Surveying the landscape of pediatric transplant training: does access need to be expanded?

10:50-12:30

MOA 9 (Plenary Room)

10:50

Plenary Session: Xenotransplant – A Role in pediatric transplantation

Full Details

Simon Urschel, Canada
How Xeno might be feasible in children with naïve immune systems

Jayme E. Locke, United States
Pediatric Xeno transplant: Crossing the barrier of Xeno-AMR

Eckhard Nagel, Germany
Ethics in xenotransplant

07:00 - 08:00 | Morning Sessions

08:00 - 09:00 | Concurrent Workshop Sessions

09:00 - 09:15 | Coffee Break

09:15 - 10:45 | Abstract Sessions

10:50 - 12:30 | Plenary and Closing Session